Achaogen's Series B Round

Achaogen raised a round of funding on October 09, 2006.

Achaogen specializes in the discovery and development of small molecules to treat infections caused by bacterial infection, and by antibiotic-resistant strains in particular. Achaogen focuses on high …

Articles about Achaogen's Series B Round: